cambridge's bluebird bio licenses delivery tech to novartis, gsk
. print
.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
.
our view: parents who don’t vaccinate put others in peril
.
. the software can help physicians administer emergency treatment more quickly and also predict the one's chances of developing dementia.
.